It's alive! ๐
๐ง๐ต๐ฒ ๐๐ฎ๐๐ฎ ๐๐ป๐ฎ๐น๐๐๐'๐ ๐๐๐ถ๐ฑ๐ฒ ๐๐ผ ๐๐ฎ๐๐๐ฒ ๐ฎ๐ป๐ฑ ๐๐ณ๐ณ๐ฒ๐ฐ๐ is out -- an introduction to causal inference in practice.
The first two chapters are available for free here: https://t.co/48apEawKp2
More below ๐
It's alive! ๐
๐ง๐ต๐ฒ ๐๐ฎ๐๐ฎ ๐๐ป๐ฎ๐น๐๐๐'๐ ๐๐๐ถ๐ฑ๐ฒ ๐๐ผ ๐๐ฎ๐๐๐ฒ ๐ฎ๐ป๐ฑ ๐๐ณ๐ณ๐ฒ๐ฐ๐ is out -- an introduction to causal inference in practice.
The first two chapters are available for free here: https://t.co/48apEawKp2
More below ๐
It's alive! ๐
๐ง๐ต๐ฒ ๐๐ฎ๐๐ฎ ๐๐ป๐ฎ๐น๐๐๐'๐ ๐๐๐ถ๐ฑ๐ฒ ๐๐ผ ๐๐ฎ๐๐๐ฒ ๐ฎ๐ป๐ฑ ๐๐ณ๐ณ๐ฒ๐ฐ๐ is out -- an introduction to causal inference in practice.
The first two chapters are available for free here: https://t.co/48apEawKp2
More below ๐
Instead, we cut to the chase and emphasize a practical workflow using step-by-step explanations and real data examples in R.
The companion website lives here
https://t.co/EBTtoESLPR and holds:
- All data and code used in the book
- Free sample chapters
- Bonus material!
New blog post! ๐จ
"From Bucher to Bayes:
A Brief Introduction to Bayesian Model-Based Network Meta-Analysis for Indirect Treatment Comparisons using R"
https://t.co/pltK7vUGOT
Imagine a short (~100-150 pages) book-length introduction to causal inference.
This would be a very pedagogical and practical text. A sort of โyour first short course on applied causal inferenceโ kind of text.
What topics would you want such a book to cover?
1/
@salonium@kroetscha Nice perspectives, thanks! Re. risk aversion, I'd add that drugs have been approved on the basis of Bayesian methods for decades. So some companies are happily using Bayes, and others now have to play catch up. Hopefully the guidance can help normalize Bayes more widely.
Imagine a short (~100-150 pages) book-length introduction to causal inference.
This would be a very pedagogical and practical text. A sort of โyour first short course on applied causal inferenceโ kind of text.
What topics would you want such a book to cover?
1/